We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Recombinant Protein Expression System Reduces Production Costs and Speeds Time to Market

By LabMedica International staff writers
Posted on 06 Oct 2009
An innovative recombinant protein system overcomes conventional microbial expression difficulties by secreting correctly folded, active proteins directly into the growth media. Breakthrough expression system reduces production costs and speeds time to market.

Ajinomoto AminoScience, LLC (Raleigh, NC,USA) announced the launch of Corynex recombinant protein expression system streamlined , more efficient process to express proteins. "Ajinomoto's innovative Corynex recombinant protein expression system reinforces 50 years of leadership within the fermentation and expression fields,” commented Jack Heaton, president of Ajinomoto AminoScience. "With the debut of our new system, we demonstrate that Ajinomoto is an unrivaled industry leader.”

This advanced technology is Ajinomoto's answer to a recent analysis of biotechnology manufacturing by BioPlan Associates, a biotechnology marketing research firm (Rockville, MD, USA). In the January 2009, the firm released a study that outlines the need for advances in manufacturing. The study describes a "reluctance” by companies to modernize with new technology and methodologies so products can be made "more efficiently and to higher clinical standards.”

"This new process shows Ajinomoto's willingness to invest in scientific efforts to improve expression systems,” said Mr. Heaton. "We have answered the industry's call to develop better technology to meet our customers' needs.”

Ajinomoto, one of the worlds' largest manufacturers of amino acids, was the first company in the world to identify, customize, and market amino acids. The company is the only U.S. manufacturer of cGMP pharmaceutical grade amino acids. Key applications include use in therapeutic pharmaceutical development, cell culture media, parenteral and clinical nutrition, health foods, and food applications.

Ajinomoto AminoScience is a supplier of pharmaceutical grade amino acids. Ajinomoto created the standards that have become the accepted benchmark for the amino acid industry. Since its development, the company has provided a steady supply of high quality amino acids while vigorously pursuing research programs and improving manufacturing processes.

Related Links:

Ajinomoto Amino Science



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Thyroid ELISA Kit
AESKULISA a-TPO

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries